Levels of Influence in the Built Environment on the Promotion of Healthy Child Development
Healthcare Quarterly · 09.07.2012 · 15sp (4) · 32-37
DOI: 10.12927/hcq.2013.22944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Healthcare Quarterly, erschienen am 09.07.2012. Verfasst von James R Dunn. Beteiligte Einrichtung: James R. Dunn, PhD, is the CI HR-PHAC chair in applied public health and the William Lyon Mackenzie King visiting chair in Canadian studies, at Harva…. Hauptthemen laut MEDLINE: Child Development, Child Welfare, Health Promotion, Residence Characteristics. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
There has been a major explosion of research on the built environment and health in the social epidemiology, urban planning, geography and other disciplines over the past several years. The author discusses the effects of children's built environments on healthy child development ‒ a departure from traditional approaches that are focused on child diseases, disorders and the avoidance of hazards and risks in the built environment. Language: en
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- James R. Dunn, PhD, is the CI HR-PHAC chair in applied public health and the William Lyon Mackenzie King visiting chair in Canadian studies, at Harvard University (2011‒2012), in Cambridge, Massachusetts. He is also an…
Zitieren
APA
Dunn, J. R. (2012). Levels of Influence in the Built Environment on the Promotion of Healthy Child Development. Healthcare Quarterly, 15sp(4), 32-37. https://doi.org/10.12927/hcq.2013.22944
Vancouver
Dunn JR. Levels of Influence in the Built Environment on the Promotion of Healthy Child Development. Healthcare Quarterly. 2012;15sp(4):32-37. doi:10.12927/hcq.2013.22944
BibTeX
@article{Dunn2012,
author = {Dunn, James R},
title = {Levels of Influence in the Built Environment on the Promotion of Healthy Child Development},
journal = {Healthcare Quarterly},
year = {2012},
volume = {15sp},
number = {4},
pages = {32--37},
doi = {10.12927/hcq.2013.22944}
}
EUVIMED